United Kingdom Health Security Agency, an Executive Agency of the Department of Health
20 capabilities
Verified Sep 2026
One of 2,380 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Birmingham Heartlands Hospital, Bordesley Green East
Bordesley Green East B9 5SS , United Kingdom
Bordesley Green East B9 5SS , United Kingdom
Accreditation
Active
UKAS
8213
ukhsa.gov.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
8213
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDF
Test Capabilities (20)
| Standard Reference | Description | Category |
|---|---|---|
| isolates | Department of Health | isolates | Department of Health | Clinical Microbiology |
| antibody | Department of Health | antibody | Department of Health | Immunology / Serology |
| Blood HIV1 Reverse transcriptase & | Department of Health | Blood HIV1 Reverse transcriptase & | Department of Health | Molecular Diagnostics / PCR |
| Blood HIV1 Reverse transcriptase & | United Kingdom Health Security Agency, an Executive Agency of the | Blood HIV1 Reverse transcriptase & | United Kingdom Health Security Agency, an Executive Agency of the | Molecular Diagnostics / PCR |
| Bronchial Lavage, | • Parainfluenza 1-4 | Bronchial Lavage, | • Parainfluenza 1-4 | Molecular Diagnostics / PCR |
| CSF Qualitative molecular detection of | • Escherichia coli K1 | CSF Qualitative molecular detection of | • Escherichia coli K1 | Molecular Diagnostics / PCR |
| CSF Qualitative molecular detection of | • Herpes simplex 1 and 2 | CSF Qualitative molecular detection of | • Herpes simplex 1 and 2 | Molecular Diagnostics / PCR |
| CSF Qualitative molecular detection of | • Human herpesvirus 6 | CSF Qualitative molecular detection of | • Human herpesvirus 6 | Molecular Diagnostics / PCR |
| Nasopharyngeal | • Adeno virus | Nasopharyngeal | • Adeno virus | Molecular Diagnostics / PCR |
| Nasopharyngeal | • RhinovirusHuman | Nasopharyngeal | • RhinovirusHuman | Molecular Diagnostics / PCR |
| Nose and/or throat Qualitative molecular detection of | • Influenza A virus H1 | Nose and/or throat Qualitative molecular detection of | • Influenza A virus H1 | Molecular Diagnostics / PCR |
| Nose and/or throat Qualitative molecular detection of | • Influenza A virus H1-2009 | Nose and/or throat Qualitative molecular detection of | • Influenza A virus H1-2009 | Molecular Diagnostics / PCR |
| Nose and/or throat Qualitative molecular detection of | • Influenza A virus H3 | Nose and/or throat Qualitative molecular detection of | • Influenza A virus H3 | Molecular Diagnostics / PCR |
| Plasma Quantitation of: | • CMV | Serum / Plasma Quantitation of: | Roche Cobas c702 using | Molecular Diagnostics / PCR |
| Plasma Quantitation of: | • CMV | Plasma Quantitation of: | • CMV | Molecular Diagnostics / PCR |
| Sputum, | • RSV | Sputum, | • RSV | Molecular Diagnostics / PCR |
| Swabs, | • SARS-CoV-2 | Swabs, | • SARS-CoV-2 | Molecular Diagnostics / PCR |
| Department of Health | Department of Health | Other |
| Materials/ | Type of test/Properties | Materials/ | Type of test/Properties | Other |
| Nasopharyngeal | Department of Health | Nasopharyngeal | Department of Health | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.